News

Nanohale AG Acquires R&D and Service Units of Scil Technology GmbH -Transaction Creates New Nanohale Subsidiary Named Formycon GmbH - 09/01/2012

Sanofi Licenses Worldwide Rights on Regenerative Treatment for Osteoarthritis and Cartilage Disorders from Scil Technology GmbH 20/12/2011

Scil Technology Establishes Independent Service Unit formycon 20/07/2011

Scil Technology Receives Public Research Grant for Novel Rheumatoid Arthrits Treatments 23/06/2011

Scil Technology appoints Christian Nafe to Chief Executive Officer 14/02/2011

Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies 29/04/2008

Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor 16/01/2008

Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study 22/05/2007

Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study 24/01/2007

Conferences & Events

27 - 30 June: Bio International ConventionWashington DC, USA
15 Sept: Binder Associates Business Development Forum, Eltville, Germany
11 - 13 Oct: BIO Technica: Hannover, Germany. Hall 9 Stand F53/1
25 - 27 Oct: CPHI Europe, Frankfurt, Germany
31 Oct - 2 Nov: Bio Europe, Düsseldorf, Germany